|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.04 BGN | +1.34% |
|
0.00% | +5.59% |
| Feb. 29 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Sopharma AD Reports Sales Results for the Month and Eleven Months Ended November 2023 | CI |
Sopharma AD reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was BGN 1,374.98 million compared to BGN 1,218.8 million a year ago. Net income was BGN 77.74 million compared to BGN 67.88 million a year ago.
Basic earnings per share from continuing operations was BGN 0.64 compared to BGN 0.56 a year ago. Diluted earnings per share from continuing operations was BGN 0.6 compared to BGN 0.57 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.59% | 546M | |
| -32.21% | 15.27B | |
| -31.97% | 10.84B | |
| -30.42% | 6.06B | |
| +8.14% | 6.04B | |
| -11.41% | 5.86B | |
| -0.88% | 4.71B | |
| +52.19% | 4.29B | |
| -12.31% | 3.61B | |
| -14.86% | 3.33B |
SOPHARMA AD 
